Business Market R...
Follow
Find
3.4K views | +4 today
Your new post is loading...
Your new post is loading...
Scooped by rnrmarketresearch
Scoop.it!

Global Alpha- Antitrypsin Deficiency Therapeutic Pipeline Industry... - RnR Market Research

Global Alpha- Antitrypsin Deficiency Therapeutic Pipeline Industry... - RnR Market Research | Business Market Research Reports | Scoop.it
RnRmarketResearch.com adds report “Alpha- Antitrypsin Deficiency – Pipeline Review, H2 2014” to its store.
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Consumer Credit in the UK – Key Trends and Opportunities to 2018 - RnR Market Research

Consumer Credit in the UK – Key Trends and Opportunities to 2018 - RnR Market Research | Business Market Research Reports | Scoop.it
Consumer Credit in the UK – Key Trends and Opportunities to 2018: Order report by calling Rnrmarketsresearch.com at +1 888 391 5441 OR send an email on...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Degenerative Disc Disease Therapeutic Pipeline Market H2 2014

Global Degenerative Disc Disease Therapeutic Pipeline Market H2 2014 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Degenerative Disc Disease – Pipeline Review, H2 2014” to its store.

 

Degenerative Disc Disease Pipeline Review, H2 2014′, provides an overview of the Degenerative Disc Disease’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Degenerative Disc Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Degenerative Disc Disease and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/degenerative-disc-disease-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

The report provides a snapshot of the global therapeutic landscape of Degenerative Disc DiseaseThe report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activitiesThe report reviews key players involved in the therapeutics development for Degenerative Disc Disease and enlists all their major and minor projectsThe report summarizes all the dormant and discontinued pipeline projectsA review of the Degenerative Disc Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sourcesPipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stagesA detailed assessment of monotherapy and combination therapy pipeline projectsCoverage of the Degenerative Disc Disease pipeline on the basis of target, MoA, route of administration and molecule typeLatest news and deals relating related to pipeline products

 

Reasons to buy

 

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop strategic initiatives by understanding the focus areas of leading companiesIdentify and understand important and diverse types of therapeutics under development for Degenerative Disc DiseasePlan mergers and acquisitions effectively by identifying key players of the most promising pipelineDevise corrective measures for pipeline projects by understanding Degenerative Disc Disease pipeline depth and focus of Indication therapeuticsDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeModify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=248287 .

(This is a premium report priced at US$2000 for a single user PDF.)

 

List of Tables

 

Number of Products under Development for Degenerative Disc Disease, H2 2014 8

Number of Products under Development for Degenerative Disc Disease - Comparative Analysis, H2 2014 9

Number of Products under Development by Companies, H2 2014 10

Number of Products under Investigation by Universities/Institutes, H2 2014 11

Comparative Analysis by Clinical Stage Development, H2 2014 12

Comparative Analysis by Early Stage Development, H2 2014 13

Comparative Analysis by Unknown Stage Development, H2 2014 14

Products under Development by Companies, H2 2014 15

Products under Investigation by Universities/Institutes, H2 2014 16

Degenerative Disc Disease - Pipeline by AnGes MG, Inc., H2 2014 17

Degenerative Disc Disease - Pipeline by Bioheart, Inc., H2 2014 18

Degenerative Disc Disease - Pipeline by Bone Therapeutics SA, H2 2014 19

Degenerative Disc Disease - Pipeline by DePuy Spine, Inc., H2 2014 20

Degenerative Disc Disease - Pipeline by Discgenics, Inc, H2 2014 21

Degenerative Disc Disease - Pipeline by ISTO Technologies, Inc., H2 2014 22

Degenerative Disc Disease - Pipeline by K-Stemcell Co., Ltd., H2 2014 23

Degenerative Disc Disease - Pipeline by Mesoblast Limited, H2 2014 24

Degenerative Disc Disease - Pipeline by TissueGene, Inc., H2 2014 25

Degenerative Disc Disease - Pipeline by Yuhan Corporation, H2 2014 26

Assessment by Monotherapy Products, H2 2014 27

Number of Products by Stage and Target, H2 2014 29

Number of Products by Stage and Mechanism of Action, H2 2014 31

Number of Products by Stage and Route of Administration, H2 2014 33

Number of Products by Stage and Molecule Type, H2 2014 35

Degenerative Disc Disease Therapeutics - Recent Pipeline Updates, H2 2014 58

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=248287 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Hearing Disorders Market Pipeline Review, H2 2014

Global Hearing Disorders Market Pipeline Review, H2 2014 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Hearing Disorders – Pipeline Review, H2 2014” to its store.

 

‘Hearing Disorders Pipeline Review, H2 2014′, provides an overview of the Hearing Disorders’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Hearing Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hearing Disorders and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/hearing-disorders-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

The report provides a snapshot of the global therapeutic landscape of Hearing DisordersThe report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activitiesThe report reviews key players involved in the therapeutics development for Hearing Disorders and enlists all their major and minor projectsThe report summarizes all the dormant and discontinued pipeline projectsA review of the Hearing Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sourcesPipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stagesA detailed assessment of monotherapy and combination therapy pipeline projectsCoverage of the Hearing Disorders pipeline on the basis of target, MoA, route of administration and molecule typeLatest news and deals relating related to pipeline products

 

Reasons to buy

 

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop strategic initiatives by understanding the focus areas of leading companiesIdentify and understand important and diverse types of therapeutics under development for Hearing DisordersPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineDevise corrective measures for pipeline projects by understanding Hearing Disorders pipeline depth and focus of Indication therapeuticsDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeModify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=248285 .

(This is a premium report priced at US$2000 for a single user PDF.)

 

List of Figures

 

Number of Products under Development for Hearing Disorders, H2 2014 10

Number of Products under Development for Hearing Disorders - Comparative Analysis, H2 2014 11

Number of Products under Development by Companies, H2 2014 12

Number of Products under Investigation by Universities/Institutes, H2 2014 14

Comparative Analysis by Clinical Stage Development, H2 2014 16

Comparative Analysis by Early Stage Products, H2 2014 17

Assessment by Monotherapy Products, H2 2014 31

Number of Products by Top 10 Targets, H2 2014 33

Number of Products by Stage and Top 10 Targets, H2 2014 34

Number of Products by Top 10 Mechanism of Actions, H2 2014 35

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 36

Number of Products by Top 10 Routes of Administration, H2 2014 37

Number of Products by Stage and Top 10 Routes of Administration, H2 2014 38

Number of Products by Top 10 Molecule Types, H2 2014 39

Number of Products by Stage and Top 10 Molecule Types, H2 2014 40

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=248285 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Hepatic (Liver) Metastasis – Pipeline Review, H2 2014

Global Hepatic (Liver) Metastasis – Pipeline Review, H2 2014 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Hepatic (Liver) Metastasis – Pipeline Review, H2 2014” to its store.

 

Hepatic (Liver) Metastasis Pipeline Review, H2 2014′, provides an overview of the Hepatic (Liver) Metastasis’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Hepatic (Liver) Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatic (Liver) Metastasis and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/hepatic-liver-metastasis-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

The report provides a snapshot of the global therapeutic landscape of Hepatic (Liver) MetastasisThe report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activitiesThe report reviews key players involved in the therapeutics development for Hepatic (Liver) Metastasis and enlists all their major and minor projectsThe report summarizes all the dormant and discontinued pipeline projectsA review of the Hepatic (Liver) Metastasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sourcesPipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stagesA detailed assessment of monotherapy and combination therapy pipeline projectsCoverage of the Hepatic (Liver) Metastasis pipeline on the basis of target, MoA, route of administration and molecule typeLatest news and deals relating related to pipeline products

 

Reasons to buy

 

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop strategic initiatives by understanding the focus areas of leading companiesIdentify and understand important and diverse types of therapeutics under development for Hepatic (Liver) MetastasisPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineDevise corrective measures for pipeline projects by understanding Hepatic (Liver) Metastasis pipeline depth and focus of Indication therapeuticsDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeModify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=248282 .

(This is a premium report priced at US$2000 for a single user PDF.)

 

List of Figures

 

Number of Products under Development for Hepatic (Liver) Metastasis, H2 2014 8

Number of Products under Development for Hepatic (Liver) Metastasis - Comparative Analysis, H2 2014 9

Number of Products under Development by Companies, H2 2014 10

Number of Products under Investigation by Universities/Institutes, H2 2014 11

Comparative Analysis by Clinical Stage Development, H2 2014 12

Comparative Analysis by Early Stage Products, H2 2014 13

Assessment by Monotherapy Products, H2 2014 23

Number of Products by Top 10 Targets, H2 2014 24

Number of Products by Stage and Top 10 Targets, H2 2014 25

Number of Products by Top 10 Mechanism of Actions, H2 2014 26

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 27

Number of Products by Top 10 Routes of Administration, H2 2014 28

Number of Products by Stage and Top 10 Routes of Administration, H2 2014 29

Number of Products by Top 10 Molecule Types, H2 2014 30

Number of Products by Stage and Top 10 Molecule Types, H2 2014 31

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=248282 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Chemotherapy Induced Nausea and Vomiting Therapeutic Pipeline Market H2 2014

Global Chemotherapy Induced Nausea and Vomiting Therapeutic Pipeline Market H2 2014 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Chemotherapy Induced Nausea and Vomiting – Pipeline Review, H2 2014” to its store.

 

Chemotherapy Induced Nausea and Vomiting Pipeline Review, H2 2014′, provides an overview of the Chemotherapy Induced Nausea and Vomiting’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Nausea and Vomiting, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Nausea and Vomiting and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/chemotherapy-induced-nausea-and-vomiting-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

The report provides a snapshot of the global therapeutic landscape of Chemotherapy Induced Nausea and VomitingThe report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activitiesThe report reviews key players involved in the therapeutics development for Chemotherapy Induced Nausea and Vomiting and enlists all their major and minor projectsThe report summarizes all the dormant and discontinued pipeline projectsA review of the Chemotherapy Induced Nausea and Vomiting products under development by companies and universities/research institutes based on information derived from company and industry-specific sourcesPipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stagesA detailed assessment of monotherapy and combination therapy pipeline projectsCoverage of the Chemotherapy Induced Nausea and Vomiting pipeline on the basis of target, MoA, route of administration and molecule typeLatest news and deals relating related to pipeline products

 

Reasons to buy

 

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop strategic initiatives by understanding the focus areas of leading companiesIdentify and understand important and diverse types of therapeutics under development for Chemotherapy Induced Nausea and VomitingPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineDevise corrective measures for pipeline projects by understanding Chemotherapy Induced Nausea and Vomiting pipeline depth and focus of Indication therapeuticsDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeModify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=248280 .

(This is a premium report priced at US$2000 for a single user PDF.)

 

List of Tables

 

Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H2 2014 9

Number of Products under Development for Chemotherapy Induced Nausea and Vomiting - Comparative Analysis, H2 2014 10

Number of Products under Development by Companies, H2 2014 12

Comparative Analysis by Late Stage Development, H2 2014 13

Comparative Analysis by Clinical Stage Development, H2 2014 14

Comparative Analysis by Early Stage Development, H2 2014 15

Comparative Analysis by Unknown Stage Development, H2 2014 16

Products under Development by Companies, H2 2014 17

Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd., H2 2014 18

Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corporation, H2 2014 19

Chemotherapy Induced Nausea and Vomiting - Pipeline by BioDelivery Sciences International, Inc., H2 2014 20

Chemotherapy Induced Nausea and Vomiting - Pipeline by Genovate Biotechnology Co., LTD., H2 2014 21

Chemotherapy Induced Nausea and Vomiting - Pipeline by Helsinn Holding S.A., H2 2014 22

Chemotherapy Induced Nausea and Vomiting - Pipeline by Heron Therapeutics, Inc., H2 2014 23

Chemotherapy Induced Nausea and Vomiting - Pipeline by INSYS Therapeutics, Inc., H2 2014 24

Chemotherapy Induced Nausea and Vomiting - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2014 25

Chemotherapy Induced Nausea and Vomiting - Pipeline by Merck & Co., Inc., H2 2014 26

Chemotherapy Induced Nausea and Vomiting - Pipeline by RedHill Biopharma Ltd., H2 2014 27

Chemotherapy Induced Nausea and Vomiting - Pipeline by Shin Nippon Biomedical Laboratories, Ltd., H2 2014 28

Chemotherapy Induced Nausea and Vomiting - Pipeline by Suda Ltd, H2 2014 29

Chemotherapy Induced Nausea and Vomiting - Pipeline by Teikoku Pharma USA, Inc., H2 2014 30

Chemotherapy Induced Nausea and Vomiting - Pipeline by Tesaro, Inc., H2 2014 31

Assessment by Monotherapy Products, H2 2014 32

Assessment by Combination Products, H2 2014 33

Number of Products by Stage and Target, H2 2014 35

Number of Products by Stage and Mechanism of Action, H2 2014 37

Number of Products by Stage and Route of Administration, H2 2014 39

Number of Products by Stage and Molecule Type, H2 2014 40

Chemotherapy Induced Nausea and Vomiting Therapeutics - Recent Pipeline Updates, H2 2014 64

Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H2 2014 77

Chemotherapy Induced Nausea and Vomiting - Discontinued Products, H2 2014 78

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=248280 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.